Alnylam Pharmaceuticals
ALNY
#1124
Rank
$20.93 B
Marketcap
$156.34
Share price
3.10%
Change (1 day)
-64.60%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company